Agenda
Welcome
Digitalization along the value chain
Digitalization to improve disease understanding, identify new drug targets and leads
Digitalization to enable early R&D and clinical development
Real world evidence to improve clinical R&D and patient care
Digital platforms accelerating development, manufacturing and commercialization
Roche Information Solutions (RIS): Bringing insights into action for better healthcare
Q&A
Karl Mahler, Head of Investor Relations
Alan Hippe; Chief Financial and IT Officer Roche
Mark McCarthy, Executive Director Human Genetics, gRED
Christian Gossens, Digital Biomarkers, Global Area Head, pRED
Jacqueline Law, Vice president, Head of Corporate Strategy, Flatiron Health
Steve Guise; Global Head, Pharma Informatics
Moritz Hartmann, Global Head of Roche Information Solutions, Roche Diagnostics